Autres langues PROCEPT BioRobotics Corporation

Actions

PRCT

US74276L1052

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
68,1 ^USD	+0,02 %		+8,70 %	+62,49 %

15/05	Transcript : PROCEPT BioRobotics Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM
06/05	PROCEPT BIOROBOTICS CORPORATION : Piper Sandler toujours à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PROCEPT BioRobotics : 2024 Bank of America Heathcare Conf	15/05
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference	13/05
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia	06/05
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia	06/05
PROCEPT BioRobotics Corporation Announces Long-Term, Real-World Data Showing the Benefits of Aquablation Therapy for the Treatment of Symptomatic Prostatic Hyperplasia	06/05
Procept BioRobotics Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing	06/05
Procept BioRobotics Insider Sold Shares Worth $1,916,428, According to a Recent SEC Filing	06/05
PROCEPT BioRobotics : AUA 2024 Investor Presentation	03/05
PROCEPT BioRobotics : 2024 AUA Investor Day	03/05
PROCEPT BioRobotics : Q1 2024 Procept BioRobotics Earnings Conference Call	02/05
PROCEPT BioRobotics : Investor Presentation – May 2024	02/05
Procept BioRobotics Shares Rise After Q1 Loss Narrows, Revenue Increases; 2024 Revenue Guidance Revised	01/05
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
Earnings Flash (PRCT) PROCEPT BIOROBOTICS Reports Q1 Revenue $44.5M, vs. Street Est of $41.7M	01/05
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	01/05
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	01/05
Procept Biorobotics Corporation Increases Revenue Guidance for Full Year 2024	01/05
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia	29/04
PROCEPT BioRobotics : UK Modern Slavery Transparency Statement	26/04
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting	23/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PROCEPT BioRobotics Corporation

Actions

PRCT

US74276L1052

Autres langues

Filtres